Trump heralds a ‘historic breakthrough’ in the R&D fight against Covid-19 now comes the instant backlash as the FDA provides a controversial assist -…

Zheng Wei and William Pan met in a molecular biology study group in college in Guangzhou, China.

In the following decades, the duo transformed from college note-takers to co-founders of Taicang, China-based Connect Biopharmaceuticals. And on Monday, they completed a $115 million Series C to propel their pipeline of immune modulators.

The amount and the type of investors that we have in this round it really is a big boost for the company, said Wei, who most recently served as director of immunology at San Diego-based Arena Pharmaceuticals.

Read More

Read more here:

Trump heralds a 'historic breakthrough' in the R&D fight against Covid-19 now comes the instant backlash as the FDA provides a controversial assist -...

Related Posts
Tags: